RAMP2 influences glucagon receptor pharmacology via trafficking and signalling

被引:0
|
作者
Cegla, J. [1 ]
Jones, B. J. [1 ]
Gardiner, J. V. [1 ]
Hodson, D. J. [1 ]
Marjot, T. [1 ]
Tan, T. M. [1 ]
Bloom, S. R. [1 ]
机构
[1] Imperial Coll London, Div Diabet Endocrinol & Metab, 6th Floor Commonwealth Bldg, London, England
基金
英国惠康基金; 英国生物技术与生命科学研究理事会;
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
558
引用
收藏
页码:S267 / S267
页数:1
相关论文
共 50 条
  • [1] RAMP2 Influences Glucagon Receptor Pharmacology via Trafficking and Signaling
    Cegla, Jaimini
    Jones, Ben J.
    Gardiner, James V.
    Hodson, David J.
    Marjot, Thomas
    McGlone, Emma R.
    Tan, Tricia M.
    Bloom, Stephen R.
    ENDOCRINOLOGY, 2017, 158 (08) : 2680 - 2693
  • [2] Receptor Activity-Modifying Protein 2 (RAMP2) alters glucagon receptor trafficking in hepatocytes with functional effects on receptor signalling
    McGlone, Emma Rose
    Manchanda, Yusman
    Jones, Ben
    Pickford, Phil
    Inoue, Asuka
    Carling, David
    Bloom, Stephen R.
    Tan, Tricia
    Tomas, Alejandra
    MOLECULAR METABOLISM, 2021, 53
  • [3] Modulation of Glucagon Receptor Pharmacology by Receptor Activity-modifying Protein-2 (RAMP2)
    Weston, Cathryn
    Lu, Jing
    Li, Naichang
    Barkan, Kerry
    Richards, Gareth O.
    Roberts, David J.
    Skerry, Timothy M.
    Poyner, David
    Pardamwar, Meenakshi
    Reynolds, Christopher A.
    Dowell, Simon J.
    Willars, Gary B.
    Ladds, Graham
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2015, 290 (38) : 23009 - 23022
  • [4] Negative allosteric modulation of the glucagon receptor by RAMP2
    Kumar, Kaavya Krishna
    O'Brien, Evan S.
    Habrian, Chris H.
    Latorraca, Naomi R.
    Wang, Haoqing
    Tuneew, Inga
    Montabana, Elizabeth
    Marqusee, Susan
    Hilger, Daniel
    Isacoff, Ehud Y.
    Mathiesen, Jesper Mosolff
    Kobilka, Brian K.
    CELL, 2023, 186 (07) : 1465 - +
  • [5] Negative allosteric modulation of the glucagon receptor by RAMP2
    O'Brien, Evan S.
    Kumar, Kaavya Krishna
    Habrian, Chris
    Latorraca, Naomi R.
    Wang, Haoqing
    Tuneew, Inga
    Montabana, Elizabeth
    Marqusee, Susan
    Hilger, Daniel
    Isacoff, Ehud Y.
    Mathiesen, Jesper M.
    Kobilka, Brian K.
    BIOPHYSICAL JOURNAL, 2023, 122 (03) : 161A - 161A
  • [6] Insights into the molecular mechanism of glucagon receptor signaling and its modulation by RAMP2
    Hilger, D.
    Kumar, K. Krisna
    O'Brien, E.
    Hu, H.
    Habrian, C.
    Latorraca, N.
    Wang, H.
    Tuneew, I.
    Giehm, L.
    Jennings, C.
    Pedersen, M. Fabricius
    Eskici, G.
    Montabana, E.
    Isakoff, E.
    Lerch, M.
    Inoue, A.
    Maqusee, S.
    Skiniotis, G.
    Mathiesen, J. Mosolff
    Kobilka, B.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2023, 396 : S12 - S12
  • [7] Distinct roles of the two receptor activity-modifying proteins (RAMP2 and RAMP3) in the human adrenorneullin (hAM) receptor trafficking
    Kuwasako, Kenji
    Kitamura, Kazuo
    Nagata, Sayaka
    Kato, Johji
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2008, 106 : 116P - 116P
  • [8] The role of native signal peptides in trafficking RAMP2 to the plasma membrane
    Witt, Kelly Monroe
    Brauer, Philip R.
    Abell, Peter W.
    Scofield, Margaret A.
    FASEB JOURNAL, 2007, 21 (05): : A427 - A427
  • [9] Adrenomedullin signalling in cardiomyocytes is dependent upon CRLR and RAMP2 expression
    Autelitano, DJ
    Ridings, R
    PEPTIDES, 2001, 22 (11) : 1851 - 1857
  • [10] Receptor Activity-Modifying Protein 2 (RAMP2) is Essential for Angiogenesis and Vascular Integrity
    Shindo, Takayuki
    Ichikawa-Shindo, Yuka
    Sakurai, Takayuki
    Kamiyoshi, Akiko
    CIRCULATION, 2008, 118 (18) : S522 - S522